HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of hypoxia-inducible factor-2α/stearoyl-CoA desaturase-1 pathway on biological behaviors of hepatoma cells induced by hypoxia].

Abstract
Objective: To investigate whether hypoxia-inducible factor-2α (HIF-2α) affects the biological behaviors of hepatoma cells through regulating stearoyl-CoA desaturase-1 (SCD1) in a hypoxic environment. Methods: HepG2 and SMMC-7721 cells were exposed to 1% O2 to establish the hypoxic models. After hepatoma cells were stimulated by hypoxia for 0, 3, 6, 12, and 24 hours, fluorescent quantitative PCR and Western blot were used to measure the mRNA and protein expression of HIF-2α and SCD1 over time. HIF-2α interfering plasmids and SCD1 inhibitor CAY10566 were used to divide the cells into blank group (nomoxia), hypoxic group (1% O2 for 12 h), hypoxic negative control group (negative HIF-2α plasmid+1% O2 for 12 h), hypoxic interference group (HIF-2α interfering plasmid+1% O2 for 12 h), hypoxic CAY group (CAY10566 10 μmol+1% O2 for 12 h), and hypoxic interference+CAY group (HIF-2α interfering plasmid+CAY10566 10 μmol+1% O2 for 12 h). Western blot was used to measure the protein expression of HIF-2α and SCD1 in hepatoma cells, CCK8 assay was used to measure the proliferative capacity of hepatoma cells, Annexin-V/PE flow cytometry was used to measure the apoptosis of hepatoma cells, and transwell invasion assay was used to measure the invasion of hepatoma cells. A one-way analysis of variance was used to compare the means of multiple samples. Results: Both HepG2 and SMMC-7721 cells showed increasing mRNA and protein expression of HIF-2α and SCD1 over the time of hypoxic induction. After the expression of HIF-2α was downregulated in a hypoxic environment, hepatoma cells showed a significant reduction in the protein expression of SCD1; inhibition of SCD1 expression had no significant effect on the protein expression of HIF-2α in hepatoma cells. After HIF-2α was interfered with and SCD1 expression was inhibited, HepG2 and SMMC-7721 cells showed significantly greater reduction in the protein expression of SCD1 than those with HIF-2α or SCD1 inhibition alone (0.53±0.04 vs 1.12±0.04 or 1.12±0.04; 0.44±0.10 vs 0.90±0.10 or 0.99±0.13) (HIF-2α: FhepG2 = 1026.89, PhepG2 = 0.00, FSMMC-7721 = 2186.22, PSMMC-7721 = 0.00; SCD1: FhepG2 = 1347.93, PhepG2 = 0.00, FSMMC-7721 = 46.43, PSMMC-7721 = 0.00). Inhibition of the expression of HIF-2α or SCD1 reduced the proliferation and invasion of HepG2 and SMMC-7721 cells and promoted apoptosis (P < 0.05); interference and downregulation of HIF-2α combined with inhibition of SCD1 expression by CAY10566 achieved significantly greater reductions in proliferation and invasion and a significantly greater increase in apoptosis rate of hepatoma cells, compared with inhibition of HIF-2α or SCD1 alone (P <0.05). Conclusion: HIF-2α/SCD1 pathway may be one of the important mechanisms for hypoxia to regulate the energy metabolism of hepatoma cells and affect their biological behaviors.
AuthorsX Q Yu, C Cai, X Du, W Shen
JournalZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology (Zhonghua Gan Zang Bing Za Zhi) Vol. 24 Issue 7 Pg. 506-512 (Jul 20 2016) ISSN: 1007-3418 [Print] China
PMID27784428 (Publication Type: Journal Article)
Chemical References
  • Basic Helix-Loop-Helix Transcription Factors
  • RNA, Messenger
  • endothelial PAS domain-containing protein 1
  • SCD1 protein, human
  • Stearoyl-CoA Desaturase
Topics
  • Apoptosis
  • Basic Helix-Loop-Helix Transcription Factors (metabolism)
  • Carcinoma, Hepatocellular (pathology)
  • Cell Hypoxia
  • Cell Line, Tumor
  • Down-Regulation
  • Humans
  • Liver Neoplasms (pathology)
  • RNA, Messenger (metabolism)
  • Signal Transduction
  • Stearoyl-CoA Desaturase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: